Qualicorp Consulting and Insurance Brokerage (QUAL3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
15 Jul, 2026Executive summary
2024 marked significant progress in the turnaround strategy, with major cost reductions, operational efficiency gains, and a reinforced organizational culture, despite a challenging sector environment.
Over 100 new products were launched, expanding the product portfolio and improving sales quality, with the lowest churn rate in years.
Strong cash flow generation enabled a reduction in net debt by R$250 million, with cash and equivalents at R$892.9 million at year-end.
Adjusted net income rose 125.2% year-over-year to R$84.5 million, reversing the prior year's loss.
The turnaround process, started in August 2023, continues as planned, with resilience shown despite industry challenges.
Financial highlights
Net revenue for 2024 was R$1,580.5 million, down 9.7% year-over-year, with Q4 at R$384.4 million, down 7.2% year-over-year.
Adjusted EBITDA for 2024 was R$680.3 million (margin 43.0%), down 12.2% year-over-year; Adjusted EBITDA minus CAC was R$554.2 million (margin 35.1%).
Recurring free cash flow was R$438.8 million in 2024 and R$85.0 million in Q4.
Net debt decreased 20.5% year-over-year to R$970.2 million, with leverage at 1.43x Adjusted EBITDA.
Fixed expenses in Q4 were R$114.2 million, down 17.3% year-over-year.
Outlook and guidance
Focus for 2025 is on operational efficiency, portfolio expansion, cost discipline, and capital allocation, with new product launches and exclusive offerings to drive growth.
Dividend distribution in 2025 will be limited to the compulsory 25%, with further payouts in 2026 dependent on performance.
Lawsuit-related expenses are expected to remain under pressure but may decrease as industry readjustments stabilize.
Latest events from Qualicorp Consulting and Insurance Brokerage
- Churn fell to 9.4% as net revenue hit R$333.0m, with strong cash flow and lower net debt.QUAL3
Q1 202615 Jul 2026 - Net revenue and income rose, churn improved, and 340 new products were launched amid portfolio changes.QUAL3
Q3 202515 Jul 2026 - Profitability and margins improved as churn hit record lows despite revenue declines.QUAL3
Q2 202515 Jul 2026 - Operational efficiency and deleveraging drive margin gains despite portfolio contraction.QUAL3
Q1 202515 Jul 2026 - Revenue and EBITDA fell, but net income, cash flow, and leverage improved amid portfolio contraction.QUAL3
Q3 202415 Jul 2026 - Adjusted net income surged 59% sequentially as EBITDA margin hit 45.4% despite portfolio decline.QUAL3
Q2 202415 Jul 2026 - Free cash flow and margins improved, but revenue and portfolio declined amid restructuring.QUAL3
Q4 20256 Jul 2026